Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation

被引:43
作者
Wulffraat, NM
Haas, PJ
Frosch, M
de Kleer, IM
Vogl, T
Brinkman, DMC
Quartier, P
Roth, J
Kuis, W
机构
[1] Univ Utrecht, Wilhelmina Childrens Hosp, Med Ctr, Dept Paediat Immunol, Utrecht, Netherlands
[2] Univ Munster, Dept Paediat, Munster, Germany
[3] Univ Munster, Inst Expt Dermatol, Munster, Germany
[4] Leiden Univ, Med Ctr, Dept Paediat, Leiden, Netherlands
[5] Hop Necker Enfants Malad, Dept Paediat Immunol Haematol & Rheumatol, Paris, France
关键词
D O I
10.1136/ard.62.3.236
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine whether myeloid related proteins (MRP8/MRP 14), a complex of two S 100 proteins related to neutrophil and monocyte activation, might be used as a marker for disease activity, and as an early indicator of relapse in juvenile idiopathic arthritis. Patients and methods: A group of 12 patients who underwent an autologous haematopoietic stem cell transplantation (ASCT) for refractory juvenile idiopathic arthritis (JIA) were studied. MRP8/MRP14 serum concentrations were determined by a sandwich enzyme linked immunosorbent assay (ELISA) as described. Improvement from baseline was described by a definition of improvement employing a core set of criteria as detailed previously by Giannini. Results: After ASCT, MRP8/MRP 14 serum concentrations in JIA showed a positive correlation with the Child Health Assessment Questionnaire (CHAQ; r = 0.80) and erythrocyte sedimentation rate (r = 0.45), but not with the total leucocyte count (r = 0.26). Mean MRP8/MRP 14 serum concentrations dropped markedly in the first three months after ASCT (p = 0.0039) and clinical parameters of disease activity such as CHAQ markedly improved (p = 0.0039). During a transient relapse there was an increase in MRP8/MRP14. Conclusions: MRP8/MRP14 serum concentration can be used as a marker for disease activity in patients who receive an ASCT for refractory JIA. This indicates a role of macrophage activation in the pathogenesis of JIA. The occurrence of MAS in three patients in this study was not preceded by significant changes in MRP8/MRP 14 concentration.
引用
收藏
页码:236 / 241
页数:6
相关论文
共 32 条
[11]  
Len C, 1999, J RHEUMATOL, V26, P909
[12]   Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration [J].
Marmont, AM ;
vanLint, MT ;
Gualandi, F ;
Bacigalupo, A .
LUPUS, 1997, 6 (06) :545-548
[13]   The gene encoding the myeloid-related protein 14 (MRP14), a calcium-binding protein expressed in granulocytes and monocytes, contains a potent enhancer element in the first intron [J].
Melkonyan, H ;
Hofmann, HA ;
Nacken, W ;
Sorg, C ;
Klempt, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (41) :27026-27032
[14]   Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: Report of five cases [J].
Mouy, R ;
Stephan, JL ;
Pillet, P ;
Haddad, E ;
Hubert, P ;
Prieur, AM .
JOURNAL OF PEDIATRICS, 1996, 129 (05) :750-754
[15]  
Newton RA, 1998, J IMMUNOL, V160, P1427
[16]   2 CALCIUM-BINDING PROTEINS IN INFILTRATE MACROPHAGES OF RHEUMATOID-ARTHRITIS [J].
ODINK, K ;
CERLETTI, N ;
BRUGGEN, J ;
CLERC, RG ;
TARCSAY, L ;
ZWADLO, G ;
GERHARDS, G ;
SCHLEGEL, R ;
SORG, C .
NATURE, 1987, 330 (6143) :80-82
[17]   Tumor necrosis factor blockers in rheumatoid arthritis. [J].
Pisetsky, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (11) :810-811
[18]  
Quartier P, 1999, LANCET, V353, P1885, DOI 10.1016/S0140-6736(05)75094-7
[19]  
Rammes A, 1997, J BIOL CHEM, V272, P9496
[20]   Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine [J].
Ravelli, A ;
DeBenedetti, F ;
Viola, S ;
Martini, A .
JOURNAL OF PEDIATRICS, 1996, 128 (02) :275-278